
Allarity Therapeutics Inc
NASDAQ:ALLR

Fundamental Analysis


Revenue & Expenses Breakdown
Allarity Therapeutics Inc
Balance Sheet Decomposition
Allarity Therapeutics Inc
Current Assets | 20.4m |
Cash & Short-Term Investments | 18.5m |
Receivables | 1.7m |
Other Current Assets | 251k |
Non-Current Assets | 12k |
PP&E | 12k |
Free Cash Flow Analysis
Allarity Therapeutics Inc
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Allarity Therapeutics Inc
Revenue
|
0
USD
|
Operating Expenses
|
-26m
USD
|
Operating Income
|
-26m
USD
|
Other Expenses
|
2m
USD
|
Net Income
|
-24m
USD
|
ALLR Profitability Score
Profitability Due Diligence
Allarity Therapeutics Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.

Score
Allarity Therapeutics Inc's profitability score is 33/100. The higher the profitability score, the more profitable the company is.
ALLR Solvency Score
Solvency Due Diligence
Allarity Therapeutics Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.

Score
Allarity Therapeutics Inc's solvency score is 55/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
ALLR Price Targets Summary
Allarity Therapeutics Inc
Dividends
Current shareholder yield for ALLR is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?